-
Sinner rips Tiafoe to reach Miami Open semis
-
US lays it on the line as WTO mulls future of global trading
-
Joy, scepticism across west Africa after UN vote on slave trade
-
Salah would be 'asset' says San Diego FC owner
-
Parmesan exports doing grate... but sales melt in Italy
-
US cannot meet Iran war-induced LNG shortfall: industry leaders
-
Trump denies being 'desperate' for Iran deal
-
US envoy to UK warns against cancelling king's visit
-
IOC's new gender testing throws up multiple questions
-
Malinin back to his best as third world skating title beckons
-
Cuban children's heart hospital makes tough choices amid US blockade
-
Oil climbs, stocks slide on uncertainty over US-Iran talks
-
Nepal's PM-to-be delivers first post-election message in rap, urges unity
-
Vernon wins wind-hit Tour of Catalonia stage as Pidcock climbs to second
-
ChatGPT's taste for literary nonsense sparks alarm
-
Paul McCartney recalls Yesterday with first album in five years
-
'True miracle': Napoleon's long-lost hat to go on display
-
Lost in space: Sperm struggles to navigate during weightless sex
-
G7 meets in France hoping to heal transatlantic Iran rift
-
IOC's gender test directive throws up multiple questions
-
Trump insists Iran operations 'extremely' ahead of schedule
-
Bab al-Mandeb Strait: another key shipping route under threat
-
Families of Kabul bombing victims still search for answers
-
Police detain French ex-cop suspected of killing mothers of his children
-
Venezuela's Maduro back in court after stunning US capture
-
Senegal victims of 'most blatant scam' in football history: federation
-
Former badminton Olympic gold winner Marin retires due to injury
-
Olympic women's sport to be limited to biological females
-
Africa sets out stall for cotton at the WTO
-
Trump's Iran war tests MAGA 'America First' creed
-
What's happening with Iran-US 'talks'?
-
WTO mulls future of global trading under cloud of Mideast war
-
US flexes 'new order' trade policy as WTO meet kicks off
-
Germany unveils rescue plan for struggling chemical sector
-
UK PM 'very keen' to curb addictive social media after US ruling
-
South Africa disinvited from G7 in France after US pressure: Pretoria
-
EU moves closer to ban sexualised AI deepfakes
-
France bids farewell to ex-PM Jospin who 'modernised' nation
-
Belarus' Lukashenko gifts automatic rifle to North Korea's Kim
-
Germany bank on team spirit to end World Cup woes
-
Venezuela's Maduro back in US court after stunning capture
-
French court orders ex-bishop to pay over 1970s child sex abuse
-
PSG Ligue 1 game postponed in between two legs of Liverpool Champions League tie
-
Iran may believe it has the upper hand as Trump seeks talks
-
EU urged to broadly restrict 'forever chemicals'
-
Italy seizes millions 'embezzled' from Ursula Andress
-
Trump says Iran 'better get serious' in Mideast war talks
-
Global trading system hit by 'worst disruptions in the past 80 years': WTO chief
-
EU accuses four porn platforms of letting children access adult content
-
Cathay Pacific raises fuel surcharge on all flights by 34%
Chinese medical portal censored after doubting herbal 'Covid remedy'
A popular Chinese medical information site has been censored by authorities for "violation of relevant laws and regulations", months after its criticism of a government-backed herbal Covid-19 treatment sent shares in a pharmaceutical giant tumbling.
DXY, which counts tech giant Tencent among its investors and runs a host of health-related services, previously questioned the value of Lianhua Qingwen, a herbal remedy marketed for fever and sore throats, as a Covid-19 treatment.
China approved the concoction -- made up of ingredients like honeysuckle and apricot seeds -- as a Covid-19 treatment in 2020, and it was distributed to Shanghai residents during the city's outbreak this year.
DXY's article was part of a wave of reports that caused shares in Lianhua Qingwen's producer -- one of China's largest traditional medicine companies -- to plunge.
The website has now been banned from posting on at least five of its Weibo social media accounts, with a notice at the top of its official page saying that due to "violation of relevant laws and regulations, this user is currently prohibited from posting".
DXY's official WeChat accounts, which typically publish multiple articles a day on medical topics, have not been updated since Monday.
The Weibo notice did not specify which regulations had been violated by DXY, which did not immediately respond to AFP's request for comment.
The Chinese government has increasingly promoted traditional medicine at home and abroad in recent years, often with nationalistic undertones.
DXY's coverage prompted criticism that it was targeting traditional Chinese medicine (TCM) in order to promote Western pharmaceuticals.
The United States and other countries have warned there is no evidence Lianhua Qingwen works to prevent or cure Covid-19, even as it has increasingly been promoted by government authorities in China and Hong Kong.
The US Food and Drug Administration has said it has not approved Lianhua Qingwen and that coronavirus-related claims about it were "not supported by competent and reliable scientific evidence".
Beijing issued its first white paper on TCM in 2016, laying out plans to build medicine centres and dispatch practitioners to developing countries in Africa and Southeast Asia.
President Xi Jinping has described TCM as a "treasure of Chinese civilisation" and has said that it should be given as much weight as other treatments.
Beijing's National Health Commission has also dispatched TCM practitioners as part of its medical reinforcement teams sent to fight Covid-19 outbreaks across the country.
M.Fischer--AMWN